Skip to main content

Rigel Pharmaceuticals Inc 10-Q for FY2025 Q2

Rigel Pharmaceuticals Inc (RIGL)

10-Q 2025-08-05 For: 2025-06-30
View Original
Added on April 06, 2026

About this 10-Q

Rigel Pharmaceuticals Inc filed this 10-Q on August 5, 2025, covering the quarter ended June 30, 2025 (FY2025 Q2).

Headline figures

Quarter ended June 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$101.69M
up 176.0% from $36.84M a year earlier
Net income
$59.61M
compared with a net loss of $1.03M a year earlier
Diluted EPS
$3.28
compared with -$0.06 a year earlier